As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has shifted from experimentation to execution — from “Should we modernize?” to “How…
Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon Ramos (Sales Development Representative) SCOPE 2026 once again brought together leaders across…
For decades, clinical trials have struggled with a deep-rooted problem: a lack of diversity. Racial and ethnic minorities, individuals in non-English-speaking communities, and patients outside of research-heavy geographies remain consistently underrepresented in studies. This isn’t just…
